JORDAN LEAL: Open Payments
NPI 1942619689 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 11 payments from 7 companies in 2025. Trend: 2023 $842 · 2024 $870 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 5 | $271 |
| SOBI, INC | 1 | $131 |
| Astellas Pharma US Inc | 1 | $127 |
| Janssen Biotech, Inc. | 1 | $119 |
| Celgene Corporation | 1 | $102 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
Products named: REZUROCK, Gamifant, Cresemba, RYBREVANT, BREYANZI, ZYNLONTA, Oncaspar.
Industry payments across KS — which companies pay providers there.
